Immunovia, Inc.’s Medical Director Dr. Thomas King Invited as Keynote Speaker by US National Cancer Institute
LUND, SWEDEN –Immunovia AB (publ) (“Immunovia”), a diagnostic company that develops and sells highly accurate blood tests for the early detection of cancer, today announced that Thomas King, MD, PhD, Medical Director of Immunovia, Inc. was invited to present to the U.S. National Cancer Institute (NCI) Pancreatic Cancer Detection Consortium (PCDC) as a keynote speaker at their upcoming Steering Committee Meeting, taking place virtually on December 13-14, 2021. Dr. Thomas King’s keynote presentation will focus on Immunovia’s recent progress on the early detection of pancreatic cancer and